Trinity Biotech PLC Files 6-K, Incorporates S-8 Filings
Ticker: TRIB · Form: 6-K · Filed: Oct 23, 2025 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Oct 23, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing-update, corporate-governance, credit-agreement
TL;DR
Trinity Biotech 6-K filed: S-8 refs updated, Constitution amended post-AGM, credit agreement modified.
AI Summary
Trinity Biotech plc filed a Form 6-K on October 23, 2025, to incorporate by reference into its existing S-8 registration statements. This filing follows the company's Annual General Meeting on September 30, 2025, where shareholders approved amendments to the company's Constitution, the results of which were previously disclosed. Additionally, Trinity Biotech and its subsidiaries have amended their credit agreement.
Why It Matters
This filing serves to update SEC registration statements, indicating ongoing corporate actions and compliance for Trinity Biotech's securities.
Risk Assessment
Risk Level: low — The filing is procedural, incorporating previous disclosures and administrative updates without new financial or operational news.
Key Players & Entities
- TRINITY BIOTECH PLC (company) — Registrant
- September 30, 2025 (date) — Date of Annual General Meeting
- October 23, 2025 (date) — Filing Date of Form 6-K
- Form S-8 (document) — Registration Statement referenced
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is being incorporated by reference into Trinity Biotech plc's Registration Statements on Form S-8 (File Nos. 333-182279, 333-195232 and 333-253070).
When was the Annual General Meeting held?
The Company's Annual General Meeting was held on September 30, 2025.
What key decisions were made at the Annual General Meeting?
Shareholders approved resolutions that resulted in amendments to the Company's Constitution.
Were there any other significant actions mentioned in the filing?
Yes, the Company and certain of its subsidiaries also amended the credit agreement.
What is the principal executive office address of Trinity Biotech plc?
The principal executive office is located at IDA Business Park, Bray, Co. Wicklow, Ireland.
Filing Stats: 310 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2025-10-23 16:32:52
Filing Documents
- zk2533873.htm (6-K) — 13KB
- exhibit_99-1.htm (EX-99.1) — 753KB
- exhibit_99-2.htm (EX-99.2) — 1807KB
- img101.jpg (GRAPHIC) — 6KB
- img102.jpg (GRAPHIC) — 4KB
- img103.jpg (GRAPHIC) — 6KB
- 0001178913-25-003554.txt ( ) — 2596KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ Susan O'Connor Susan O'Connor Interim Chief Financial Officer Date: October 23, 2025